img

Global Geographic Atrophy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Geographic Atrophy Market Insights, Forecast to 2034

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
Market Analysis and InsightsGlobal Geographic Atrophy Market
Global Geographic Atrophy market is expected to reach to US$ 1188 million in 2024, with a positive growth of %, compared with US$ 1123 million in 2022. Backed with the increasing demand from downstream industries, Geographic Atrophy industry is evaluated to reach US$ 1714 million in 2029. The CAGR will be 6.3% during 2024 to 2029.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Covers
This report presents an overview of global Geographic Atrophy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Geographic Atrophy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Apellis Pharmaceuticals
Iveric Bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche
Gensight Biologics
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
Segment by Type
Above 60 Years
Above 75 Years

Segment by Application


Late-stage (Phase III)
Phase II
Phase I
Pre-clinical stage
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Geographic Atrophy introduction, etc. Geographic Atrophy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Geographic Atrophy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Above 60 Years
1.2.3 Above 75 Years
1.3 Market by Application
1.3.1 Global Geographic Atrophy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Late-stage (Phase III)
1.3.3 Phase II
1.3.4 Phase I
1.3.5 Pre-clinical stage
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Market Perspective (2018-2029)
2.2 Global Geographic Atrophy Growth Trends by Region
2.2.1 Geographic Atrophy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Geographic Atrophy Historic Market Size by Region (2018-2024)
2.2.3 Geographic Atrophy Forecasted Market Size by Region (2024-2029)
2.3 Geographic Atrophy Market Dynamics
2.3.1 Geographic Atrophy Industry Trends
2.3.2 Geographic Atrophy Market Drivers
2.3.3 Geographic Atrophy Market Challenges
2.3.4 Geographic Atrophy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Geographic Atrophy by Players
3.1.1 Global Geographic Atrophy Revenue by Players (2018-2024)
3.1.2 Global Geographic Atrophy Revenue Market Share by Players (2018-2024)
3.2 Global Geographic Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Geographic Atrophy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Geographic Atrophy Market Concentration Ratio
3.4.1 Global Geographic Atrophy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Revenue in 2022
3.5 Global Key Players of Geographic Atrophy Head office and Area Served
3.6 Global Key Players of Geographic Atrophy, Product and Application
3.7 Global Key Players of Geographic Atrophy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Breakdown Data by Type
4.1 Global Geographic Atrophy Historic Market Size by Type (2018-2024)
4.2 Global Geographic Atrophy Forecasted Market Size by Type (2024-2029)
5 Geographic Atrophy Breakdown Data by Application
5.1 Global Geographic Atrophy Historic Market Size by Application (2018-2024)
5.2 Global Geographic Atrophy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Geographic Atrophy Market Size (2018-2029)
6.2 North America Geographic Atrophy Market Size by Type
6.2.1 North America Geographic Atrophy Market Size by Type (2018-2024)
6.2.2 North America Geographic Atrophy Market Size by Type (2024-2029)
6.2.3 North America Geographic Atrophy Market Share by Type (2018-2029)
6.3 North America Geographic Atrophy Market Size by Application
6.3.1 North America Geographic Atrophy Market Size by Application (2018-2024)
6.3.2 North America Geographic Atrophy Market Size by Application (2024-2029)
6.3.3 North America Geographic Atrophy Market Share by Application (2018-2029)
6.4 North America Geographic Atrophy Market Size by Country
6.4.1 North America Geographic Atrophy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Geographic Atrophy Market Size by Country (2018-2024)
6.4.3 North America Geographic Atrophy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Geographic Atrophy Market Size (2018-2029)
7.2 Europe Geographic Atrophy Market Size by Type
7.2.1 Europe Geographic Atrophy Market Size by Type (2018-2024)
7.2.2 Europe Geographic Atrophy Market Size by Type (2024-2029)
7.2.3 Europe Geographic Atrophy Market Share by Type (2018-2029)
7.3 Europe Geographic Atrophy Market Size by Application
7.3.1 Europe Geographic Atrophy Market Size by Application (2018-2024)
7.3.2 Europe Geographic Atrophy Market Size by Application (2024-2029)
7.3.3 Europe Geographic Atrophy Market Share by Application (2018-2029)
7.4 Europe Geographic Atrophy Market Size by Country
7.4.1 Europe Geographic Atrophy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Geographic Atrophy Market Size by Country (2018-2024)
7.4.3 Europe Geographic Atrophy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Geographic Atrophy Market Size (2018-2029)
8.2 China Geographic Atrophy Market Size by Type
8.2.1 China Geographic Atrophy Market Size by Type (2018-2024)
8.2.2 China Geographic Atrophy Market Size by Type (2024-2029)
8.2.3 China Geographic Atrophy Market Share by Type (2018-2029)
8.3 China Geographic Atrophy Market Size by Application
8.3.1 China Geographic Atrophy Market Size by Application (2018-2024)
8.3.2 China Geographic Atrophy Market Size by Application (2024-2029)
8.3.3 China Geographic Atrophy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Geographic Atrophy Market Size (2018-2029)
9.2 Asia Geographic Atrophy Market Size by Type
9.2.1 Asia Geographic Atrophy Market Size by Type (2018-2024)
9.2.2 Asia Geographic Atrophy Market Size by Type (2024-2029)
9.2.3 Asia Geographic Atrophy Market Share by Type (2018-2029)
9.3 Asia Geographic Atrophy Market Size by Application
9.3.1 Asia Geographic Atrophy Market Size by Application (2018-2024)
9.3.2 Asia Geographic Atrophy Market Size by Application (2024-2029)
9.3.3 Asia Geographic Atrophy Market Share by Application (2018-2029)
9.4 Asia Geographic Atrophy Market Size by Region
9.4.1 Asia Geographic Atrophy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Geographic Atrophy Market Size by Region (2018-2024)
9.4.3 Asia Geographic Atrophy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Geographic Atrophy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Geographic Atrophy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Geographic Atrophy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Geographic Atrophy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Details
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2018-2024)
11.1.5 Apellis Pharmaceuticals Recent Developments
11.2 Iveric Bio
11.2.1 Iveric Bio Company Details
11.2.2 Iveric Bio Business Overview
11.2.3 Iveric Bio Geographic Atrophy Introduction
11.2.4 Iveric Bio Revenue in Geographic Atrophy Business (2018-2024)
11.2.5 Iveric Bio Recent Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Details
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2018-2024)
11.3.5 Alkeus Pharmaceuticals Recent Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Details
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Business (2018-2024)
11.4.5 Hemera Biosciences Recent Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Details
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Business (2018-2024)
11.5.5 Allegro Ophthalmics Recent Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Details
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2018-2024)
11.6.5 Stealth BioTherapeutics Recent Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Details
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2018-2024)
11.7.5 Gyroscope Therapeutics Recent Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Details
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2018-2024)
11.8.5 Regenerative Patch Technologies Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Geographic Atrophy Introduction
11.9.4 Roche Revenue in Geographic Atrophy Business (2018-2024)
11.9.5 Roche Recent Developments
11.10 Gensight Biologics
11.10.1 Gensight Biologics Company Details
11.10.2 Gensight Biologics Business Overview
11.10.3 Gensight Biologics Geographic Atrophy Introduction
11.10.4 Gensight Biologics Revenue in Geographic Atrophy Business (2018-2024)
11.10.5 Gensight Biologics Recent Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Details
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2018-2024)
11.11.5 NGM Biopharmaceuticals Recent Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Business (2018-2024)
11.12.5 AstraZeneca Recent Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Details
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2018-2024)
11.13.5 Lineage Cell Therapeutics Recent Developments
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Business (2018-2024)
11.14.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Geographic Atrophy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Above 60 Years
Table 3. Key Players of Above 75 Years
Table 4. Global Geographic Atrophy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Geographic Atrophy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Geographic Atrophy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Geographic Atrophy Market Share by Region (2018-2024)
Table 8. Global Geographic Atrophy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Geographic Atrophy Market Share by Region (2024-2029)
Table 10. Geographic Atrophy Market Trends
Table 11. Geographic Atrophy Market Drivers
Table 12. Geographic Atrophy Market Challenges
Table 13. Geographic Atrophy Market Restraints
Table 14. Global Geographic Atrophy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Geographic Atrophy Revenue Share by Players (2018-2024)
Table 16. Global Top Geographic Atrophy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2022)
Table 17. Global Geographic Atrophy Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Geographic Atrophy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Geographic Atrophy, Headquarters and Area Served
Table 20. Global Key Players of Geographic Atrophy, Product and Application
Table 21. Global Key Players of Geographic Atrophy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Geographic Atrophy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Geographic Atrophy Revenue Market Share by Type (2018-2024)
Table 25. Global Geographic Atrophy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Geographic Atrophy Revenue Market Share by Type (2024-2029)
Table 27. Global Geographic Atrophy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Geographic Atrophy Revenue Share by Application (2018-2024)
Table 29. Global Geographic Atrophy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Geographic Atrophy Revenue Share by Application (2024-2029)
Table 31. North America Geographic Atrophy Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Geographic Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Geographic Atrophy Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Geographic Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Geographic Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Geographic Atrophy Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Geographic Atrophy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Geographic Atrophy Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Geographic Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Geographic Atrophy Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Geographic Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Geographic Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Geographic Atrophy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Geographic Atrophy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Geographic Atrophy Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Geographic Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Geographic Atrophy Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Geographic Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Geographic Atrophy Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Geographic Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Geographic Atrophy Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Geographic Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Geographic Atrophy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Geographic Atrophy Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Geographic Atrophy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Geographic Atrophy Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Geographic Atrophy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Geographic Atrophy Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Geographic Atrophy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Geographic Atrophy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Geographic Atrophy Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Geographic Atrophy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Apellis Pharmaceuticals Company Details
Table 64. Apellis Pharmaceuticals Business Overview
Table 65. Apellis Pharmaceuticals Geographic Atrophy Product
Table 66. Apellis Pharmaceuticals Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 67. Apellis Pharmaceuticals Recent Developments
Table 68. Iveric Bio Company Details
Table 69. Iveric Bio Business Overview
Table 70. Iveric Bio Geographic Atrophy Product
Table 71. Iveric Bio Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 72. Iveric Bio Recent Developments
Table 73. Alkeus Pharmaceuticals Company Details
Table 74. Alkeus Pharmaceuticals Business Overview
Table 75. Alkeus Pharmaceuticals Geographic Atrophy Product
Table 76. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 77. Alkeus Pharmaceuticals Recent Developments
Table 78. Hemera Biosciences Company Details
Table 79. Hemera Biosciences Business Overview
Table 80. Hemera Biosciences Geographic Atrophy Product
Table 81. Hemera Biosciences Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 82. Hemera Biosciences Recent Developments
Table 83. Allegro Ophthalmics Company Details
Table 84. Allegro Ophthalmics Business Overview
Table 85. Allegro Ophthalmics Geographic Atrophy Product
Table 86. Allegro Ophthalmics Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 87. Allegro Ophthalmics Recent Developments
Table 88. Stealth BioTherapeutics Company Details
Table 89. Stealth BioTherapeutics Business Overview
Table 90. Stealth BioTherapeutics Geographic Atrophy Product
Table 91. Stealth BioTherapeutics Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 92. Stealth BioTherapeutics Recent Developments
Table 93. Gyroscope Therapeutics Company Details
Table 94. Gyroscope Therapeutics Business Overview
Table 95. Gyroscope Therapeutics Geographic Atrophy Product
Table 96. Gyroscope Therapeutics Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 97. Gyroscope Therapeutics Recent Developments
Table 98. Regenerative Patch Technologies Company Details
Table 99. Regenerative Patch Technologies Business Overview
Table 100. Regenerative Patch Technologies Geographic Atrophy Product
Table 101. Regenerative Patch Technologies Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 102. Regenerative Patch Technologies Recent Developments
Table 103. Roche Company Details
Table 104. Roche Business Overview
Table 105. Roche Geographic Atrophy Product
Table 106. Roche Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 107. Roche Recent Developments
Table 108. Gensight Biologics Company Details
Table 109. Gensight Biologics Business Overview
Table 110. Gensight Biologics Geographic Atrophy Product
Table 111. Gensight Biologics Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 112. Gensight Biologics Recent Developments
Table 113. NGM Biopharmaceuticals Company Details
Table 114. NGM Biopharmaceuticals Business Overview
Table 115. NGM Biopharmaceuticals Geographic Atrophy Product
Table 116. NGM Biopharmaceuticals Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 117. NGM Biopharmaceuticals Recent Developments
Table 118. AstraZeneca Company Details
Table 119. AstraZeneca Business Overview
Table 120. AstraZeneca Geographic Atrophy Product
Table 121. AstraZeneca Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 122. AstraZeneca Recent Developments
Table 123. Lineage Cell Therapeutics Company Details
Table 124. Lineage Cell Therapeutics Business Overview
Table 125. Lineage Cell Therapeutics Geographic Atrophy Product
Table 126. Lineage Cell Therapeutics Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 127. Lineage Cell Therapeutics Recent Developments
Table 128. Allergan Company Details
Table 129. Allergan Business Overview
Table 130. Allergan Geographic Atrophy Product
Table 131. Allergan Revenue in Geographic Atrophy Business (2018-2024) & (US$ Million)
Table 132. Allergan Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geographic Atrophy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Geographic Atrophy Market Share by Type: 2022 VS 2029
Figure 3. Above 60 Years Features
Figure 4. Above 75 Years Features
Figure 5. Global Geographic Atrophy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Geographic Atrophy Market Share by Application: 2022 VS 2029
Figure 7. Late-stage (Phase III) Case Studies
Figure 8. Phase II Case Studies
Figure 9. Phase I Case Studies
Figure 10. Pre-clinical stage Case Studies
Figure 11. Geographic Atrophy Report Years Considered
Figure 12. Global Geographic Atrophy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Geographic Atrophy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Geographic Atrophy Market Share by Region: 2022 VS 2029
Figure 15. Global Geographic Atrophy Market Share by Players in 2022
Figure 16. Global Top Geographic Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Geographic Atrophy Revenue in 2022
Figure 18. North America Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Geographic Atrophy Market Share by Type (2018-2029)
Figure 20. North America Geographic Atrophy Market Share by Application (2018-2029)
Figure 21. North America Geographic Atrophy Market Share by Country (2018-2029)
Figure 22. United States Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Geographic Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Geographic Atrophy Market Share by Type (2018-2029)
Figure 26. Europe Geographic Atrophy Market Share by Application (2018-2029)
Figure 27. Europe Geographic Atrophy Market Share by Country (2018-2029)
Figure 28. Germany Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Geographic Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Geographic Atrophy Market Share by Type (2018-2029)
Figure 36. China Geographic Atrophy Market Share by Application (2018-2029)
Figure 37. Asia Geographic Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Geographic Atrophy Market Share by Type (2018-2029)
Figure 39. Asia Geographic Atrophy Market Share by Application (2018-2029)
Figure 40. Asia Geographic Atrophy Market Share by Region (2018-2029)
Figure 41. Japan Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Geographic Atrophy Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Geographic Atrophy Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Geographic Atrophy Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Geographic Atrophy Market Share by Country (2018-2029)
Figure 51. Brazil Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Geographic Atrophy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 58. Iveric Bio Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 59. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 60. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 61. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 62. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 63. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 64. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 65. Roche Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 66. Gensight Biologics Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 67. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 68. AstraZeneca Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 69. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 70. Allergan Revenue Growth Rate in Geographic Atrophy Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries